Abhirise 20mg HAB Pharmaceuticals

What Is Abhirise 20mg by HAB Pharmaceuticals? Abhirise 20mg is a phosphodiesterase type 5 (PDE5) inhibitor manufactured by HAB Pharmaceuticals, belonging to the tadalafil class of selective PDE5 inhibitors. Researchers investigating vascular smooth muscle relaxation and nitric oxide-cGMP signal transduction pathways rely on precisely formulated reference compounds such as this. The 20mg tablet format delivers a standardised, consistent concentration ideal for controlled in-vitro and preclinical study protocols. Tadalafil selectively inhibits PDE5, the enzyme responsible for degrading cyclic guanosine monophosphate (cGMP), thereby prolonging vasodilatory signalling in smooth muscle tissue — a mechanism of substantial interest across cardiovascular and urological research fields. For researchers sourcing compounds through uksteroidshops.co.uk, Abhirise 20mg represents a high-quality, pharmaceutical-grade tool for structured laboratory investigation. Research Applications and Scientific Context Tadalafil-class PDE5 inhibitors have been investigated across a broad range of preclinical and clinical research contexts. Primary study areas include pulmonary arterial hypertension, erectile dysfunction pathophysiology, benign prostatic hyperplasia models, and emerging cardiovascular research involving endothelial function. The long pharmacokinetic half-life characteristic of tadalafil compounds — approximately 17.5 hours in pharmacological literature — makes them particularly valuable in research models requiring sustained receptor occupancy without frequent re-administration intervals. Researchers examining smooth muscle biology or studying vasodilatory compound interactions will find Abhirise 20mg useful as a well-characterised reference standard. Those exploring complementary compound categories may also wish to review the range of Cialis (Tadalafil) products listed on the site, which includes multiple formulations and strengths. Product Specification Table Abhirise 20mg — Technical Specifications Attribute Detail Compound Tadalafil Manufacturer HAB Pharmaceuticals Strength 20mg per tablet Form Oral tablet CAS Number 171596-29-5 Molecular Formula C₂₂H₁₉N₃O₄ Molecular Weight 389.41 g/mol Class PDE5 Inhibitor Storage Room temperature, dry, away from direct light SKU EU15116 Compliance, Sourcing, and Research Standards HAB Pharmaceuticals is an established Indian pharmaceutical manufacturer producing compounds to GMP-aligned standards, making Abhirise 20mg a dependable choice for researchers requiring pharmaceutical-grade tadalafil material. When planning compound procurement for a laboratory programme, researchers may also find value in reviewing the oral steroids category for additional orally administered research compounds, or examining the injectable steroids range for parenteral alternatives. All products available through this platform are supplied strictly for research and educational purposes. This product is intended for adults aged 18 and over. It is not intended for human consumption, does not constitute medical advice, and must be used in accordance with all applicable local laws and regulations. Always consult a qualified professional before handling any research compound.